A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

NCT03495102 · Completed

Last updated 2026-05-28

This clinical trial tests the effects of the medication dulaglutide on blood sugar control in adults with type 2 diabetes.

Status Completed The study has finished.

Phase Phase 3 Confirms effectiveness in a large group before approval.

Type Interventional (clinical trial)

Design Randomized, double-blind treatment study

Participants 1,842 people

Who can join Ages 18+ · all sexes

Timeline Started 2018-04 · est. completion 2019-10

Where 208 sites · Argentina, Austria, Canada, Greece, Hungary, Israel, Italy, Mexico, Poland, Puerto Rico, Romania, Russia, Slovakia, Spain, Taiwan, United States

What this study is testing ClinicalTrials.gov NCT03495102 ↗

Description as written by the study sponsor.

The purpose of this study is to evaluate the efficacy and safety of investigational doses of once weekly dulaglutide when added to metformin in participants with type 2 diabetes with inadequate blood sugar control.

Treatments tested

Dulaglutide also known as LY2189265 Drug

Administered SC

Main thing measured	Change in Hemoglobin A1c (HbA1c) From Baseline
Sponsor	Eli Lilly and Company
Conditions studied	Diabetes Mellitus, Type 2
GLP-1 drugs	dulaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT03495102 ↗